Rehmannia Glutinosa Extract Activates Endothelial Progenitor Cells in a Rat Model of Myocardial Infarction through a SDF-1 α/CXCR4 Cascade

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Wang, Ying Bin ^a,b   Liu, Yun Fang ^a   Lu, Xiao Ting ^a   Yan, Fang Fang ^b   Wang, Bo ^b   Bai, Wen Wu ^a   Zhao, Yu Xia ^b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CD133 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; MESSENGER RNA; PLERIXAFOR; REHMANNIA GLUTINOSA EXTRACT; SODIUM CHLORIDE; STROMAL CELL DERIVED FACTOR 1ALPHA; TROPONIN T; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL COUNT; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; ENDOTHELIAL PROGENITOR CELL; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MORPHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RAT; SURGICAL TECHNIQUE; TREATMENT DURATION; TREATMENT RESPONSE; UPREGULATION; WESTERN BLOTTING;

EID: 84872576228     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0217149     Document Type: Erratum

References (40)

1. Orlic D, Hill JM, Arai AE, (2002) Stem cells for myocardial regeneration. Circ Res 91(12): 1092-1102.
2. Caplice NM, Gersch BJ, (2003) Stem cells to repair the heart. A clinical perspective. Circ Res 92(1): 6-8.
3. Strauer BE, Brehm M, Zeus T, Köstering M, Hernandez A, et al. (2002) Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106(15): 1913-1918.
4. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, et al. (1999) Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization. Circ Res 85(1): 221-228.
5. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, et al. (2001) Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia. Circulation 103: 634-637.
6. Rafii S, Lyden D, (2003) Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9(6): 702-12.
7. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, et al. (2001) Increase in endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 102: 2885-2890.
8. Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, et al. (2004) Effects of intracoronary infusion of peripheral blood stem-cells mobilized with granulocyte-colony stimulating factor on left ventricular systolic function and rest enosis after coronary stenting in myocardial infarction: the MAGIC cell randomized clinical trial. Lancet 363 (9411): 751-756.
9. Mendez-Ferrer S, Lucas D, Battista M, et al. (2008) Hematopoietic stem cell release is regulated by circadian oscillations. Nature 452(7186): 442-7.
10. Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, et al. (1999) Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283(5403): 845-848.
11. Tang YL, Zhu W, Cheng M, Chen L, Zhang J, et al. (2009) Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res 104(10): 1209-1216.
12. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, et al. (2004) Stromal Cell-Derived Factor-1alpha Plays a Critical Role in Stem Cell Recruitment to the Heart After Myocardial Infarction but Is Not Sufficient to Induce Homing in the Absence of Injury. Circulation 110: 3300-3305.
13. Frederick JR, Fitzpatrick JR 3rd, McCormick RC, Harris DA, Kim AY, et al (2010) Stromal Cell-Derived Factor-1alpha Activation of Tissue-Engineered Endothelial Progenitor Cell Matrix Enhances Ventricular Function After Myocardial Infarction by Inducing Neovasculogenesis. Circulation 122: S107-S117.
14. Haider HK, Jiang S, Idris NM, Ashraf M, (2008) IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res 103(11): 1300-1308.
15. Zhang RX, Li MX, Jia ZP, (2008) Rehmannia glutinosa: Review of botany, chemistry and pharmacology. J Ethnopharmacol 117: 199-214.
16. Liu FJ, Cheng JP, Ru XB, Feng XW, Gu GM, et al. (1994) Effect of Rehmannia glutinosa polysaccharides on hematogenesis in mice. Chin J Pham Toxicol 8: 118.
17. Yu Z, Wang J, Li GS, Wang YS, (2001) Experimental study on rehmannioside D in the action of nourishing yin, enriching the blood and reducing the blood sugar. J Trandit Chin Med 28: 240-242.
18. Chae HJ, Kim HR, Kim DS, Woo ER, Cho YG, et al. (2005) Saeng-Ji-Hwang has a protective effect on adriamycin-induced cytotoxicity in cardiac muscle cells. Life Sciences 76: 2027-2042.
19. Lin Jiang, Nai-xian Zhang, Wei Mo, Rui Wan, Chun-gu Ma, et al. (2008) Rehmannia inhibits adipocyte differentiation and adipogenesis. Biochem Biophys Res Commun 371: 185-190.
20. Oshio H, Naruse Y, Inouye H (1981) Quantitative analysis of iridoid glycosides of Rehmanniae Radix. Shoyakugaku Zasshi 35, 291-294.
21. Davani S, Marandin A, Mersin N, Royer B, Kantelip B, et al. (2003) Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 108(Suppl 1): II253-II258.
22. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, et al. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New Engl J Med 348: 593-600.
23. Werner N, Junk S, Laufs U, Link A, Walenta K, et al. (2003) Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93: e17-e24.
24. Aiwu SHI, Xiaobin WANG, Fengxiang LU, (2009) Ginsenoside Rg1 promotes endothelial progenitor cell migration and proliferation. Acta Pharmacol Sin 30 (3): 299-306.
25. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, et al. (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1-7.
26. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, et al. (2002) Human endothelial progenitor cells from type II diabetic's exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106: 2781-6.
27. Torzewski M, Klouche M, Hock J, Messner M, Dorweiler B, et al. (1998) Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion. Arterioscler Thromb Vasc Biol 18: 369-378.
28. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods 25: 402-408.
29. Rosenkilde MM, Gerlach LO, Jakobsen JS, Skerlj RT, Bridger GJ,et al. Molecular Mechanism of AMD3100 Antagonism in the CXCR4 Receptor. J Biol Chem 279(4): 3033-3041.
30. De Lemos JA, Morrow DA, (2002) Brain Natriuretic Peptide Measurement in Acute Coronary Syndromes: ready for clinical application? Circulation. 106(23): 2868-2870.
31. Kucia M, Reca R, Jala VR, Dawn B, Ratajczak J, et al. (2005) Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells. Leukemia 19(7): 1118-1127.
32. Wojciech W, (2005) Tendera (2005) Mobilization of bone marrow-derived progenitor cells in acute coronary syndromes. Folia Histochem Cytobiol 43(4): 229-32.
33. Carmen Urbich, Stefanie Dimmeler, (2004) Endothelial Progenitor Cells Characterization and Role in Vascular Biology. Circ Res 95: 343-353.
34. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, et al. (2000) Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95: 952-958.
35. Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, et al. (2000) In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95: 3106-3112.
36. Iwami Y, Masuda H, Asahara T, (2004) Endothelial progenitor cells: past, state of the art, and future. J Cell Mol Med 8: 488-497.
37. Zhang L, Yang R, Han ZC, (2006) Transplantation of umbilical cord blood derived endothelial progenitor cells: a promising method of therapeutic revascularisation. Eur J Haematol 76(1): 1-8.
38. Rae PC, Kelly RD, Egginton S, St John JC, (2011) Angiogenic potential of endothelial progenitor cells and embryonic stem cells. Vascular Cell 3: 11.
39. P.Crump M, Gong JH, Loetscher P, Rajarathnam K, et al. (1997) Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J 16(23): 6996-7007.
40. Huang XQ, Shen JH, Cui M, Shen LL, Luo XM, et al. (2003) Molecular dynamics simulations on SDF-1α: binding with CXCR4 receptor. Biophys J 84(1): 171-184.